Cargando…

Comprehensive Contact Tracing, Testing and Sequencing Show Limited Transmission of SARS-CoV-2 between Children in Schools in Norway, August 2020 to May 2021

The role of children in the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in schools has been a topic of controversy. In this study among school contacts of SARS-CoV-2 positive children in 43 contact-investigations, we investigated SARS-CoV-2 transmission in Norway, August 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Winje, Brita Askeland, Ofitserova, Trine Skogset, Brynildsrud, Ola Brønstad, Greve-Isdahl, Margrethe, Bragstad, Karoline, Rykkvin, Rikard, Hungnes, Olav, Lund, Hilde Marie, Nygård, Karin, Meijerink, Hinta, Brandal, Lin Thorstensen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705768/ https://www.ncbi.nlm.nih.gov/pubmed/34946187 http://dx.doi.org/10.3390/microorganisms9122587

Ejemplares similares

Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020
por: Brandal, Lin T, et al.
Publicado: (2021)

Effectiveness of BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron infection in adolescents, Norway, August 2021 to January 2022
por: Veneti, Lamprini, et al.
Publicado: (2023)

Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021
por: Seppälä, Elina, et al.
Publicado: (2021)

Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019
por: Brandal, Lin T., et al.
Publicado: (2022)

Molecular Epidemiology of the Norwegian SARS-CoV-2 Delta Lineage AY.63
por: Moen, Line Victoria, et al.
Publicado: (2022)

No difference in risk of hospitalization between reported cases of the SARS-CoV-2 Delta variant and Alpha variant in Norway
por: Veneti, Lamprini, et al.
Publicado: (2022)

Large outbreak of mumps virus genotype G among vaccinated students in Norway, 2015 to 2016
por: Veneti, Lamprini, et al.
Publicado: (2018)

Poor neutralizing antibody responses against SARS‐CoV‐2 Omicron BQ.1.1 and XBB in Norway in October 2022
por: Vikse, Elisabeth Lea, et al.
Publicado: (2023)

Wanting to or having to – a qualitative study of experiences and attitudes towards migrant screening for tuberculosis in Norway
por: Nordstoga, Ingunn, et al.
Publicado: (2019)

Measles vaccine coverage among children born to Somali immigrants in Norway
por: Jenness, Sherin Marie, et al.
Publicado: (2021)

Community spread and late season increased incidence of oseltamivir‐resistant influenza A(H1N1) viruses in Norway 2016
por: Bragstad, Karoline, et al.
Publicado: (2019)

The impact of global lineage dynamics, border restrictions, and emergence of the B.1.1.7 lineage on the SARS-CoV-2 epidemic in Norway
por: Osnes, Magnus N, et al.
Publicado: (2021)

Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
por: Wisløff, Torbjørn, et al.
Publicado: (2018)

The Risk of Invasive Pneumococcal Disease Differs between Risk Groups in Norway Following Widespread Use of the 13-Valent Pneumococcal Vaccine in Children
por: Winje, Brita Askeland, et al.
Publicado: (2021)

Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022
por: Veneti, Lamprini, et al.
Publicado: (2022)

Abrupt termination of the 2019/20 influenza season following preventive measures against COVID-19 in Denmark, Norway and Sweden
por: Emborg, Hanne-Dorthe, et al.
Publicado: (2021)

Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 –May 2021
por: Veneti, Lamprini, et al.
Publicado: (2021)

A qualitative study of health experiences of Ethiopian asylum seekers in Norway
por: Schein, Yvette Louise, et al.
Publicado: (2019)

Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021
por: Brandal, Lin T., et al.
Publicado: (2021)

Estimated vaccine effectiveness against SARS-CoV-2 Delta and Omicron infections among health care workers and the general adult population in Norway, August 2021 – January 2022
por: Langlete, Petter, et al.
Publicado: (2023)

Treatment completion for latent tuberculosis infection in Norway: a prospective cohort study
por: Schein, Yvette Louise, et al.
Publicado: (2018)

Temporal patterns in count-to-ten fetal movement charts and their associations with pregnancy characteristics: a prospective cohort study
por: Winje, Brita Askeland, et al.
Publicado: (2012)

Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973–2030
por: Meijerink, Hinta, et al.
Publicado: (2017)

High frequency of enterovirus D68 in children hospitalised with respiratory illness in Norway, autumn 2014
por: Bragstad, Karoline, et al.
Publicado: (2015)

The ‘Finnish new variant of Chlamydia trachomatis’ escaping detection in the Aptima Combo 2 assay is widespread across Norway, June to August 2019
por: Johansen, Tone Bjordal, et al.
Publicado: (2019)

The First GAEN-Based COVID-19 Contact Tracing App in Norway Identifies 80% of Close Contacts in “Real Life” Scenarios
por: Meijerink, Hinta, et al.
Publicado: (2021)

Placental Pathology in Pregnancies with Maternally Perceived Decreased Fetal Movement - A Population-Based Nested Case-Cohort Study
por: Winje, Brita Askeland, et al.
Publicado: (2012)

Estimation of the incidence of hospitalisation for non-invasive pneumococcal pneumonia in the Norwegian population aged 50 years and older
por: Lyngstad, Trude Marie, et al.
Publicado: (2022)

Cost-utility analysis of a universal pneumococcal vaccination programme for older adults in Norway
por: Nymark, Liv Solvår, et al.
Publicado: (2022)

Human to animal transmission of influenza A(H1N1)pdm09 in a turkey breeder flock in Norway
por: Sjurseth, Siri Kulberg, et al.
Publicado: (2017)

Risk factors, immune response and whole‐genome sequencing of SARS‐CoV‐2 in a cruise ship outbreak in Norway
por: Gravningen, Kirsten, et al.
Publicado: (2022)

School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay
por: Winje, Brita Askeland, et al.
Publicado: (2008)

Risk factors for SARS-CoV-2 infection and hospitalisation in children and adolescents in Norway: a nationwide population-based study
por: Størdal, Ketil, et al.
Publicado: (2022)

Healthcare workers’ perceptions and experiences of communicating with people over 50 years of age about vaccination: a qualitative evidence synthesis
por: Glenton, Claire, et al.
Publicado: (2021)

Infection prevention guidelines and considerations for paediatric risk groups when reopening primary schools during COVID-19 pandemic, Norway, April 2020
por: Johansen, Tone Bjordal, et al.
Publicado: (2020)

Experience with open schools and preschools in periods of high community transmission of COVID-19 in Norway during the academic year of 2020/2021
por: Stebbings, Sara, et al.
Publicado: (2022)

Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study
por: Winje, Brita Askeland, et al.
Publicado: (2019)

Secondary attack rates of COVID-19 in Norwegian families: a nation-wide register-based study
por: Telle, Kjetil, et al.
Publicado: (2021)

Genomic epidemiology and population structure of Neisseria gonorrhoeae in Norway, 2016–2017
por: Alfsnes, Kristian, et al.
Publicado: (2020)

Using qualitative research to develop an elaboration of the TIDieR checklist for interventions to enhance vaccination communication: short report
por: Glenton, Claire, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tc25vjuno41q852lkstiabg9cj